Printer Friendly

Articles from M2 Pharma (January 29, 2016)

1-15 out of 15 article(s)
Title Author Type Words
Dr Reddy's Laboratories passes US FDA approval for ZEMBRACE SymTouch injection for acute migraine episodes. 163
HCA achieves better net income of USD582m in Q4 2015. 190
Heron Therapeutics elects Kimberly J. Manhard as EVP of drug development. 134
Kentucky dental surgery recruits three new members to dental team. 161
Knee Reconstruction Devices Market to Reach 7.94bn by 2020, According to MarketsandMarkets Data. 432
Lilly posts higher net income of USD478.4m for Q4 2015. Financial report 204
Merck passes US FDA's priority review approval of ZEPATIER (elbasvir and grazoprevir) for treating Chronic Hepatitis C Virus Genotype 1 or 4 Infection. 313
Myeloma UK signs new contract with Structural Genomics Consortium. 197
Neurocrine Biosciences & AbbVie commences first of two planned Phase 3 clinical studies of Elagolix in patients with uterine fibroids. Clinical report 275
Radius Health signs worldwide clinical collaboration with Novartis Pharmaceuticals. 216
Stemedica Cell Technologies enrolment for phase I/IIa study to assess patients with ischemic stroke now completed. 185
SurModics posts lower Q1 fiscal 2016 diluted GAAP earnings per share from continuing operations of USD0.19. Financial report 180
Teva & Eagle Pharmaceuticals partnership unveils Injection for CLL & NHL patients. 154
The Pharmacy Technician Certification Board names new director of Strategic Alliances. 166
Verathon Launches New BladderScan Prime Portable Ultrasound Instrument. 212

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |